Company
TTFactor is the market connection company for IFOM and IEO research. TTFactor's mission is the commercial exploitation of IFOM and IEO fully integrated cancer capabilities, represented by:
- One of the largest Molecular Oncology research center in Europe (The Campus IFOM-IEO);
- Highly reputed Hospital focused on cancer with more than 200 clinical trials ongoing and a history of more than 30.000 patients treated in experimental protocols (IEO);
- Molecular Medicine Program launched as an active interface between the basic research of the IFOM-IEO Campus and the IEO clinical expertise;
- An innovative Drug Discovery Program (DDP) entirely funded by IEO to successfully bring small molecules drugs candidates up to an IND, through a scientific team with a strong industrial trackrecord.
We are committed to identifying, protecting and transferring any intellectual property generated through research or clinical practise which may benefit from industrial development to become a product available to patients and the public at large.
Download the Company Full Text PDF Brochure
TEAM
vvvvv
- Pier Giuseppe Pelicci, Chairman - IEO
- Claudio Basilico - New York University
- Andrea Cuomo - ST Microelectronics
- Marco Foiani - IFOM
- Isaac Kohlberg - Harvard University
- Tomas Lindhal FRS-Cancer Research UK
- Stefano Michelini - IEO
- Elisabetta Petrucci - FIRC
- Domenico Triarico - IEO
- Raffaela Zoboli - IFOM
BUSINESS DEVELOPMENT ADVISORY BOARD
TTFactor's Business Development Advisory Board is composed of accomplished leaders from the healthcare industry and Venture Capitals who bring their experience in science, medicine, business and finance to prioritize TTFactor's patent portfolio and foster its commercial exploitation.
- Giulio Draetta, MD Anderson Cancer Center
- Isaac Kohlberg, Harvard University
- Nagesh Mahantappa, Celgene Corporation
- Kazumi Shiosaki, MPM Capital
- Katherine Turner, R&D Consultant
Why technology transfer?
Forthcoming Events
Join us at:
- BIO International Convention, Boston, June 18-21, 2012 - Meet us at BIO!
- BIO Japan, Pacifico Yokohama, 10-12 October, 2012
Past events
Drug discovery program
A unique effort to discover new treatments for cancer, the DDP leverages the strong biology and clinical relevance of IEO’s research in cancer with industry-competitive drug discovery experience.
